Emergence Global Enterprises Inc.

CNSX:EMRG Stock Report

Market Cap: CA$4.9m

Emergence Global Enterprises Past Earnings Performance

Past criteria checks 0/6

Emergence Global Enterprises has been growing earnings at an average annual rate of 44.4%, while the Personal Products industry saw earnings growing at 20.9% annually. Revenues have been growing at an average rate of 55% per year.

Key information

44.4%

Earnings growth rate

46.3%

EPS growth rate

Personal Products Industry Growth35.8%
Revenue growth rate55.0%
Return on equity-3.3%
Net Margin-6.0%
Last Earnings Update31 Jul 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Emergence Global Enterprises makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CNSX:EMRG Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Jul 222010
30 Apr 222010
31 Jan 222010
31 Oct 212010
31 Jul 211610
30 Apr 210700
31 Jan 210700
31 Oct 200700
31 Jul 200000
30 Apr 200000
31 Jan 200000
31 Oct 190000
31 Jul 190000
30 Apr 190000
31 Jan 190000
31 Oct 180000
31 Jul 18-1000
30 Apr 18-1000
31 Jan 180000
31 Oct 170000
31 Jul 172000
30 Apr 172-110
31 Jan 172-110
31 Oct 164-220
31 Jul 1611-540
30 Apr 1622-540
31 Jan 1635-450
31 Oct 1539-540
31 Jul 1544-130
30 Apr 1544-120
31 Jan 1539-120
31 Oct 1441020
31 Jul 1438020
31 Jan 1434020
31 Oct 1334020

Quality Earnings: EMRG is currently unprofitable.

Growing Profit Margin: EMRG is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EMRG is unprofitable, but has reduced losses over the past 5 years at a rate of 44.4% per year.

Accelerating Growth: Unable to compare EMRG's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EMRG is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (-10.5%).


Return on Equity

High ROE: EMRG has a negative Return on Equity (-3.32%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/06 11:45
End of Day Share Price 2023/03/09 00:00
Earnings2022/07/31
Annual Earnings2021/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Emergence Global Enterprises Inc. is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Siddharth RajeevFundamental Research Corp.